Research Topics | Martin DarveauSummaryCountry: Canada Publications
| Collaborators |
Detail Information
Publications
Recombinant human erythropoietin use in intensive careMartin Darveau
Faculty of Pharmacy, University of Montreal and Cité de la Santé de Laval, Quebec, Canada
Ann Pharmacother 36:1068-74. 2002..To review the literature concerning the role of recombinant human erythropoietin (rHuEPO) in reducing the need for transfusion in critically ill patients...- Erythropoietic response to two epoetin alfa regimens in critically ill patients: a pilot studyMartin Darveau
Pharmacy Department, Hôtel Dieu de Lévis, Levis, Quebec, Canada
Pharmacotherapy 26:1587-94. 2006..To compare the erythropoietic responses and tolerability of two recombinant human erythropoietin (EPO) regimens... - Bench-to-bedside review: iron metabolism in critically ill patientsMartin Darveau
Faculty of Pharmacy, University of Montreal, Quebec, Canada
Crit Care 8:356-62. 2004..The present article also reviews the literature describing the iron status in critically ill patients and explores the role of iron supplementation in this setting... - Comment: use of epoetin alfa in critically ill patientsMartin Darveau
Ann Pharmacother 38:1325-6. 2004